[Humoral and cellular immunity in patients with hematologic and lymph node neoplasms following levamisole immunomodulation].
D000276:Adjuvants, Immunologic; D000917:Antibody Formation; D006801:Humans; D007111:Immunity, Cellular; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology*; D007978:Levamisole / Q000494:pharmacology* / Q000627:therapeutic use; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology*
D000276:Adjuvants, Immunologic; D007978:Levamisole
Parametry odporności humoralnej i komórkowej u chorych z chorobami nowotworowymi krwi i wezlów chlonnych poddanych immunomodulacji lewamisolem.